Veracyte, Inc. (NASDAQ: VCYT) announced the acquisition of Convergent Genomics, adding the UroAmp urinary tumor DNA (utDNA) testing platform to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE